From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years.
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.